Company Filing History:
Years Active: 2025
Title: Michael Deci: Innovator in Cancer Treatment
Introduction
Michael Deci is an accomplished inventor based in Amherst, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His expertise lies in developing compositions and methods that target specific cellular functions.
Latest Patents
Michael Deci holds a patent for "Compositions and methods to block and bind CXCR4 to modulate cellular function." This patent includes compositions comprising antibodies directed to the N-terminal domain of CXCR4. The antibody may be a single-chain variable fragment (scFv) and can be fused to an RNA binding peptide. The fusion protein can be complexed to RNA interference (RNAi) molecules, such as micro RNA. These complexes are designed for targeted delivery of RNAi molecules to CXCR4-expressing cancer cells, as well as inhibiting the binding of CXCR4 to CXCL12. He has 1 patent in total.
Career Highlights
Michael Deci is affiliated with the State University of New York, where he conducts his research and development work. His role at the university allows him to collaborate with other experts in the field and contribute to advancements in cancer therapies.
Collaborations
One of his notable coworkers is Juliane Nguyen, with whom he collaborates on various research projects. Their combined expertise enhances the potential for innovative solutions in cancer treatment.
Conclusion
Michael Deci's work exemplifies the impact of innovative research in the medical field. His contributions to cancer treatment through targeted therapies highlight the importance of continued research and development in this area.